Tanja Gonska

Hospital for Sick Children
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Highly effective drugs modulating the defective protein encoded by the CFTR gene have revolutionized cystic fibrosis (CF) therapy. Preclinical drug-testing on human nasal epithelial (HNE) cell cultures and 3-dimensional human intestinal organoids (3D HIO) are used to address patient-specific variation in drug response and to optimize individual treatment for people with CF. This study is the first to report comparable CFTR functional responses to CFTR modulator treatment among patients with different classes of CFTR gene variants using the three methods of 2D HIO, 3D HIO, and HNE. Furthermore, 2D HIO showed good correlation to clinical outcome markers. A larger measurable CFTR functional range and access to the apical membrane were identified as advantages of 2D HIO over HNE and 3D HIO, respectively. Our study thus expands the utility of 2D intestinal monolayers as a preclinical drug testing tool for CF.

Year:

2023

Collaborators (6)

Chee Ooi

University of New South Wales

AUSTRALIA
View details

Bernadette Prentice

New South Wales Department of Planning and Environment

AUSTRALIA
View details

Bowen Li

Associate Professor

University of Toronto

CANADA
View details

Yue Xu

Assistant Professor

University of Toronto

CANADA
View details

Jim Hu

Professor

University of Toronto

CANADA
View details

Haissi Cui

Assistant Professor

University of Toronto

CANADA
View details